Berikutnya

Putar otomatis

Upfront Immunotherapy for Metastatic Kidney Cancer

0 Tampilan • 06/26/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis